Hepatitis E and Acute Liver Failure in Pregnancy

Journal of Clinical and Experimental Hepatology

Volumn 3, Issue 3, 2013, Pages 213-224

  Shalimar, ^a   Acharya, Subrat K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Fetal transmission; Mortality; Pathogenesis

Indexed keywords

HEPATITIS E ANTIBODY; HEPATITIS E VACCINE; PROGESTERONE; PROGESTERONE RECEPTOR;

ACUTE LIVER FAILURE; AWARENESS; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; FETUS DISEASE; FETUS OUTCOME; GENE; GENE MUTATION; GENOTYPE; GENOTYPING TECHNIQUE; HAND WASHING; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; MALNUTRITION; MEDICAL INFORMATION; MOLECULAR PATHOLOGY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT EDUCATION; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE RECEPTOR GENE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; VIREMIA; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 84884533203     PISSN: 09736883     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jceh.2013.08.009     Document Type: Review

References (95)

1. Tam A.W., Smith M.M., Guerra M.E., et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991, 185:120-131.
2. Yarbough P.O., Tam A.W., Fry K.E., et al. Hepatitis E virus: identification of type-common epitopes. JVirol 1991, 65:5790-5797.
3. Iqbal M., Ahmed A., Qamar A., et al. An outbreak of enterically transmitted non-A, non-B hepatitis in Pakistan. Am J Trop Med Hyg 1989, 40:438-443.
4. Zhuang H., Cao X.Y., Liu C.B., Wang G.M. Epidemiology of hepatitis E in China. Gastroenterol Jpn 1991, 26:135-138.
5. Naidu S.S., Viswanathan R. Infectious hepatitis in pregnancy during Delhi epidemic. Indian J Med Res 1957, 45:71-76.
6. Sreenivasan M.A., Banerjee K., Pandya P.G., et al. Epidemiological investigations of an outbreak of infectious hepatitis in Ahmedabad city during 1975-76. Indian J Med Res 1978, 67:197-206.
7. Khuroo M.S., Teli M.R., Skidmore S., Sofi M.A., Khuroo M.I. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981, 70:252-255.
8. Acharya S.K., Dasarathy S., Kumer T.L., et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996, 23:1448-1455.
9. Naik S.R., Aggarwal R., Salunke P.N., Mehrotra N.N. Alarge waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992, 70:597-604.
10. Khuroo M.S., Duermeyer W., Zargar S.A., Ahanger M.A., Shah M.A. Acute sporadic non-A, non-B hepatitis in India. Am J Epidemiol 1983, 118:360-364.
11. Bile K., Isse A., Mohamud O., et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994, 51:466-474.
12. Boccia D., Guthmann J.P., Klovstad H., et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 2006, 42:1679-1684.
13. Kwo P.Y., Schlauder G.G., Carpenter H.A., et al. Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc 1997, 72:1133-1136.
14. Dalton H.R., Stableforth W., Thurairajah P., et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008, 20:784-790.
15. Matsuda H., Okada K., Takahashi K., Mishiro S. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. JInfect Dis 2003, 188:944.
16. Rein D.B., Stevens G.A., Theaker J., Wittenborn J.S., Wiersma S.T. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012, 55:988-997.
17. Gurley E.S., Halder A.K., Streatfield P.K., et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection. Am J Public Health 2012, 102:2248-2254.
18. Aggarwal R. Hepatitis E: epidemiology and natural history. JClin Exp Hepatol 2013, 3:125-133.
19. Pattanayak S., Singha P., Pal S.C., Rao C.K., Shrivastav J.B. An outbreak of infectious hepatitis in Siliguri, 1966. Indian J Med Res 1968, 56:1605-1616.
20. Lee W.M. Acute liver failure. Semin Respir Crit Care Med 2012, 33:36-45.
21. Bernal W., Auzinger G., Wendon J. Prognostic utility of the bilirubin lactate and etiology score. Clin Gastroenterol Hepatol 2009, 7:249.
22. Hadem J., Tacke F., Bruns T., et al. Acute liver failure study group Germany. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol 2012, 10:664-669.
23. Gow P.J., Jones R.M., Dobson J.L., Angus P.W. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. JGastroenterol Hepatol 2004, 19:154-159.
24. Bhatia V., Singhal A., Panda S.K., Acharya S.K. A20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse?. Hepatology 2008, 48:1577-1585.
25. Khuroo M.S., Kamili S. Aetiology and prognostic factors in acute liver failure in India. JViral Hepat 2003, 10:224-231.
26. Ichai P., Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl 2008, 14:S67-S79.
27. Oketani M., Ido A., Tsubouchi H. Changing etiologies and outcomes of acute liver failure: a perspective from Japan. JGastroenterol Hepatol 2011, 1:65-71.
28. Khuroo M.S., Rustgi V.K., Dawson G.J., et al. Spectrum of hepatitis E virus infection in India. JMed Virol 1994, 43:281-286.
29. Aggarwal R., Shahi H., Naik S., Yachha S.K., Naik S.R. Evidence in favour of high infection rate with hepatitis E virus among young children in India. JHepatol 1997, 26:1425-1426.
30. Khuroo M.S., Khuroo M.S. Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then. Hepatol Int 2010, 4:494-499.
31. Myint K.S., Endy T.P., Shrestha M.P., et al. Hepatitis E antibody kinetics in Nepalese patients. Trans R Soc Trop Med Hyg 2006, 100:938-941.
32. Lindemann M.L., Gabilondo G., Romero B., de la Maza O.M., Pérez-Gracia M.T. Low prevalence of hepatitis E infection among pregnant women in Madrid. Spain J Med Virol 2010, 82:1666-1668.
33. Stoszek S.K., Abdel-Hamid M., Saleh D.A., et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006, 100:95-101.
34. Begum N., Devi S.G., Husain S.A., Kumar Ashok, Kar P. Seroprevalence of subclinical HEV infection in pregnant women from north India: a hospital based study. Indian J Med Res 2009, 130:709-713.
35. Gad Y.Z., Mousa N., Shams M., Elewa A. Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt. Asian J Transfus Sci 2011, 5:136-139.
36. Mesquita J.R., Conceição-Neto N., Valente-Gomes G., Gonçalves G., Nascimento M.S. Antibodies to hepatitis E in Portuguese mothers and their newborns. JMed Virol 2013, 85:1377-1378.
37. Adjei A.A., Tettey Y., Aviyase J.T., et al. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J 2009, 6:108.
38. Caron M., Kazanji M. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 2008, 5:158.
39. Cevrioglu A.S., Altindis M., Tanir H.M., Aksoy F. Investigation of the incidence of hepatitis E virus among pregnant women in Turkey. JObstet Gynaecol Res 2004, 30:48-52.
40. Anty R., Ollier L., Péron J.M., et al. First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South-Eastern France. JClin Virol 2012, 54:76-78.
41. Karnad D.R., Lapsia V., Krishnan A., Salvi V.S. Prognostic factors in obstetric patients admitted to an Indian intensive care unit. Crit Care Med 2004, 32:1294-1299.
42. Beniwal M., Kumar A., Kar P., Jilani N., Sharma J.B. Prevalence and severity of acute viral hepatitis and fulminant hepatitis during pregnancy: a prospective study from north India. Indian J Med Microbiol 2003, 21:184-185.
43. Jaiswal S.P., Jain A.K., Naik G., Soni N., Chitnis D.S. Viral hepatitis during pregnancy. Int J Gynaecol Obstet 2001, 72:103-108.
44. Rasheeda C.A., Navaneethan U., Jayanthi V. Liver disease in pregnancy and its influence on maternal and fetal mortality: a prospective study from Chennai, Southern India. Eur J Gastroenterol Hepatol 2008, 20:362-364.
45. Patra S., Kumar A., Trivedi S.S., Puri M., Sarin S.K. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007, 147:28-33.
46. Hamid S.S., Jafri S.M., Khan H., Shah H., Abbas Z., Fields H. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?. JHepatol 1996, 25:20-27.
47. Khuroo M.S., Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. JViral Hepat 2003, 10:61-69.
48. Viswanathan R. Epidemiology. Indian J Med Res 1957, 45:1-29.
49. Tandon B.N., Joshi Y.K., Jain S.K., Gandhi B.M., Mathiesen L.R., Tandon H.D. An epidemic of non-A, non-B hepatitis in North India. Indian J Med Res 1982, 75:739-744.
50. Rab M.A., Bile M.K., Mubarik M.M., et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Am J Trop Med Hyg 1997, 57:151-157.
51. Nayak N.C., Panda S.K., Datta R., et al. Aetiology and outcome of acute viral hepatitis in pregnancy. JGastroenterol Hepatol 1989, 4:345-352.
52. Acharya S.K., Madan K., Dattagupta S., Panda S.K. Viral hepatitis in India. Natl Med J India 2006, 19:203-217.
53. Arankalle V.A., Paranjape S., Emerson S.U., Purcell R.H., Walimbe A.M. Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993). JGen Virol 1999, 80:1691-1700.
54. Gupta H., Tandon B.N., Sriramachari S., Joshi Y.K., Iyenger B. Animal transmission of enteric non-A, non-B hepatitis infection to Macaca mulatta by faeco-oral route. Indian J Med Res 1990, 91:87-90.
55. Uchida T., Win K.M., Suzuki K., et al. Serial transmission of a putative causative virus of enterically transmitted non-A, non-B hepatitis to Macaca fascicularis and Macaca mulatta. Jpn J Exp Med 1990, 60:13-21.
56. Tsarev S.A., Tsareva T.S., Emerson S.U., et al. Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. JInfect Dis 1995, 172:31-37.
57. Arankalle V.A., Chadha M.S., Banerjee K., Srinivasan M.A., Chobe L.P. Hepatitis E virus infection in pregnant rhesus monkeys. Indian J Med Res 1993, 97:4-8.
58. Weinberg E.D. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 1984, 6:814-831.
59. Girardi G. Complement inhibition keeps mothers calm and avoids fetal rejection. Immunol Invest 2008, 37:645-659.
60. Lowry P.J. The placenta is simply a neuroendocrine parasite. JNeuroendocrinol 2008, 20:700-704.
61. Taglauer E.S., Yankee T.M., Petroff M.G. Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy. JReprod Immunol 2009, 80:12-21.
62. Beagley K.W., Gockel C.M. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003, 38:13-22.
63. Prabhu S.B., Gupta P., Durgapal H., et al. Study of cellular immune response against Hepatitis E virus (HEV). JViral Hepat 2011, 18:587-594.
64. Aggarwal R., Shukla R., Jameel S., et al. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. JViral Hepat 2007, 14:283-292.
65. Jilani N., Das B.C., Husain S.A., et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. JGastroenterol Hepatol 2007, 22:676-682.
66. Pal R., Aggarwal R., Naik S.R., Das V., Das S., Naik S. Immunological alterations in pregnant women with acute hepatitis E. JGastroenterol Hepatol 2005, 20:1094-1101.
67. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994, 10:405-455.
68. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376:167-170.
69. Prusty B.K., Hedau S., Singh A., Kar P., Das B.C. Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol Med 2007, 13:518-526.
70. Siiteri P.K., Febres F., Clemens L.E., Chang R.J., Gondos B., Stites D. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant?. Ann N Y Acad Sci 1977, 286:384-397.
71. Kyurkchiev D., Ivanova-Todorova E., Kyurkchiev S.D. New target cells of the immunomodulatory effects of progesterone. Reprod Biomed Online 2010, 21:304-311.
72. Bose P.D., Das B.C., Kumar A., Gondal R., Kumar D., Kar P. High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. JHepatol 2011, 54:1107-1113.
73. Hussaini S.H., Skidmore S.J., Richardson P., Sherratt L.M., Cooper B.T., O'Grady J.G. Severe hepatitis E infection during pregnancy. JViral Hepat 1997, 4:51-54.
74. Adams R.H., Combes R. Viral hepatitis during pregnancy. JAMA 1965, 192:195-198.
75. Borkakoti J., Hazam R.K., Mohammad A., Kumar A., Kar P. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy?. JMed Virol 2013, 85:620-626.
76. Kar P., Jilani N., Husain S.A., et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy?. Am J Gastroenterol 2008, 103:2495-2501.
77. Mishra N., Walimbe A.M., Arankalle V.A. Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients. Virus Genes 2013, 46:47-53.
78. Tandon B.N., Bernauau J., O'Grady J., et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. JGastroenterol Hepatol 1999, 14:403-404.
79. Chauhan A., Jameel S., Dilawari J.B., Chawla Y.K., Kaur U., Ganguly N.K. Hepatitis E virus transmission to a volunteer. Lancet 1993, 341:149-150.
80. Clayson E.T., Myint K.S.A., Snitbhan R., et al. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. JInfect Dis 1995, 172:927-933.
81. Aggarwal R., Kini D., Sofat S., Naik S.R., Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000, 356:1081-1082.
82. Nanda S.K., Ansari I.H., Acharya S.K., Jameel S., Panda S.K. Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology 1995, 108:225-230.
83. Singh S., Mohanty A., Joshi Y.K., Deka D., Mohanty S., Panda S.K. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003, 70:37-39.
84. Kumar R.M., Uduman S., Rana S., Kochiyil J.K., Usmani A., Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001, 100:9-15.
85. Khuroo M.S., Kamili S., Khuroo M.S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. JViral Hepat 2009, 16:519-523.
86. Kumar A., Beniwal M., Kar P., Sharma J.B., Murthy N.S. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004, 85:240-244.
87. Moreno E.G., García G.I., Gómez S.R., et al. Fulminant hepatic failure during pregnancy successfully treated by orthotopic liver transplantation. Transplantation 1991, 52:923-926.
88. Eguchi S., Yanaga K., Fujita F., et al. Living-related right lobe liver transplantation for a patient with fulminant hepatic failure during the second trimester of pregnancy: report of a case. Transplantation 2002, 73:1970-1971.
89. Chibber R.M., Usmani M.A., Al-Sibai M.H. Should HEV infected mothers breast feed?. Arch Gynecol Obstet 2004, 270:15-20.
90. Dhiman R.K., Seth A.K., Jain S., Chawla Y.K., Dilawari J.B. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998, 43:1311-1316.
91. Kumar R., Shalimar, Sharma H., et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut 2012, 61:1068-1075.
92. Khuroo M.S., Dar M.Y. Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992, 11:113-116.
93. Arankalle V.A., Chadha M.S., Dama B.M., Tsarev S.A., Purcell R.H., Banerjee K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. JViral Hepat 1998, 5:199-204.
94. Shrestha M.P., Scott R.M., Joshi D.M., et al. Safety and efficacy of a recombinant hepatitis E vaccine. NEngl J Med 2007, 356:895-903.
95. Zhu F.C., Zhang J., Zhang X.F., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.